• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A method for the analysis of randomized trials with compliance information: an application to the Multiple Risk Factor Intervention Trial.

作者信息

Mark S D, Robins J M

机构信息

Biostatistics Branch, National Cancer Institute, Washington, DC.

出版信息

Control Clin Trials. 1993 Apr;14(2):79-97. doi: 10.1016/0197-2456(93)90012-3.

DOI:10.1016/0197-2456(93)90012-3
PMID:8500308
Abstract

The standard approach to analyzing randomized trials ignores information on postrandomization compliance. Application of these methods results in estimates that may lack the desired causal interpretation. We employ a new method of estimation and analyze data from the Multiple Risk Factor Intervention Trial (MRFIT) to estimate the causal effect of quitting cigarette smoking. Our procedure utilizes a method proposed by Robins and Tsiatis and allows us to take advantage of postrandomization smoking history without requiring untenable assumptions about the comparability of compliers and noncompliers. We contrast the performance of our method and the standard intent-to-treat analysis in the MRFIT data and in simulated data in which compliance rates are varied.

摘要

相似文献

1
A method for the analysis of randomized trials with compliance information: an application to the Multiple Risk Factor Intervention Trial.
Control Clin Trials. 1993 Apr;14(2):79-97. doi: 10.1016/0197-2456(93)90012-3.
2
A causal proportional hazards estimator for the effect of treatment actually received in a randomized trial with all-or-nothing compliance.一种用于在具有全有或全无依从性的随机试验中实际接受治疗效果的因果比例风险估计器。
Biometrics. 2003 Mar;59(1):100-5. doi: 10.1111/1541-0420.00012.
3
Estimating causal effects from a randomized clinical trial when noncompliance is measured with error.在测量不依从存在误差的情况下,从随机临床试验估计因果效应。
Biostatistics. 2018 Jan 1;19(1):103-118. doi: 10.1093/biostatistics/kxx029.
4
Profiling compliers and noncompliers for instrumental variable analysis with covariates: A weighting approach.对协变量进行工具变量分析的依从者和不依从者进行分析:一种加权方法。
PLoS One. 2023 Jun 15;18(6):e0283223. doi: 10.1371/journal.pone.0283223. eCollection 2023.
5
Estimating the causal effect of smoking cessation in the presence of confounding factors using a rank preserving structural failure time model.使用秩保持结构失效时间模型估计存在混杂因素时戒烟的因果效应。
Stat Med. 1993 Sep 15;12(17):1605-28. doi: 10.1002/sim.4780121707.
6
A case of data alteration in the Multiple Risk Factor Intervention Trial (MRFIT). The MRFIT Research Group.多重危险因素干预试验(MRFIT)中的一例数据篡改事件。MRFIT研究小组。
Control Clin Trials. 1991 Dec;12(6):731-40. doi: 10.1016/0197-2456(91)90036-l.
7
Cigarette smoking and mortality. MRFIT Research Group.吸烟与死亡率。多重危险因素干预试验研究组
Prev Med. 1991 Sep;20(5):638-54. doi: 10.1016/0091-7435(91)90060-h.
8
The multiple risk factor intervention trial (MRFIT). V. Intervention on smoking.多重危险因素干预试验(MRFIT)。五、吸烟干预。
Prev Med. 1981 Jul;10(4):476-500. doi: 10.1016/0091-7435(81)90061-x.
9
Long-term prognostic significance of isolated minor electrocardiographic T-wave abnormalities in middle-aged men free of clinical cardiovascular disease (The Multiple Risk Factor Intervention Trial [MRFIT]).中年无临床心血管疾病男性单纯轻微心电图T波异常的长期预后意义(多重危险因素干预试验[MRFIT])
Am J Cardiol. 2002 Dec 15;90(12):1391-5. doi: 10.1016/s0002-9149(02)02881-3.
10
Brief description of the Multiple Risk Factor Intervention Trial.多重危险因素干预试验简介。
Am J Clin Nutr. 1997 Jan;65(1 Suppl):191S-195S. doi: 10.1093/ajcn/65.1.191S.

引用本文的文献

1
Long-Term Real-World Survival of Immunotherapy Compared to Chemotherapy for Metastatic Nonsmall Cell Lung Cancer: A Propensity Score-Matched Analysis.免疫疗法与化疗治疗转移性非小细胞肺癌的长期真实世界生存情况:一项倾向评分匹配分析
Thorac Cancer. 2025 Jan;16(1):e15535. doi: 10.1111/1759-7714.15535.
2
Mediterranean Diet Adherence, Gut Microbiota and Parkinson's Disease: A Systematic Review.地中海饮食依从性、肠道微生物群与帕金森病:系统评价。
Nutrients. 2024 Jul 9;16(14):2181. doi: 10.3390/nu16142181.
3
Estimation of treatment effect in presence of noncompliance and competing risks: a simulation study.
存在不依从和竞争风险时的治疗效果估计:一项模拟研究。
Sci Rep. 2023 Aug 18;13(1):13477. doi: 10.1038/s41598-023-40538-2.
4
The need for increased pragmatism in cardiovascular clinical trials.心血管临床试验需要增加务实性。
Nat Rev Cardiol. 2022 Nov;19(11):737-750. doi: 10.1038/s41569-022-00705-w. Epub 2022 May 17.
5
Semiparametric estimation of structural failure time models in continuous-time processes.连续时间过程中结构失效时间模型的半参数估计。
Biometrika. 2020 Mar;107(1):123-136. doi: 10.1093/biomet/asz057. Epub 2019 Oct 29.
6
The Moderate Alcohol and Cardiovascular Health Trial (MACH15): Design and methods for a randomized trial of moderate alcohol consumption and cardiometabolic risk.中重度饮酒与心血管健康试验(MACH15):一项随机饮酒量与心血管代谢风险试验的设计与方法。
Eur J Prev Cardiol. 2020 Dec;27(18):1967-1982. doi: 10.1177/2047487320912376. Epub 2020 Apr 6.
7
Improved two-stage estimation to adjust for treatment switching in randomised trials: g-estimation to address time-dependent confounding.改进的两阶段估计法以调整随机试验中的治疗转换:用于解决时间依存性混杂的g估计法。
Stat Methods Med Res. 2020 Oct;29(10):2900-2918. doi: 10.1177/0962280220912524. Epub 2020 Mar 30.
8
Adherence adjustment in the Coronary Drug Project: A call for better per-protocol effect estimates in randomized trials.冠心病药物治疗项目中的依从性调整:呼吁在随机试验中更好地估计符合方案效应。
Clin Trials. 2016 Aug;13(4):372-8. doi: 10.1177/1740774516634335. Epub 2016 Mar 7.
9
Adjusting for the Confounding Effects of Treatment Switching-The BREAK-3 Trial: Dabrafenib Versus Dacarbazine.调整治疗转换的混杂效应——BREAK-3试验:达拉非尼与达卡巴嗪对比
Oncologist. 2015 Jul;20(7):798-805. doi: 10.1634/theoncologist.2014-0429. Epub 2015 Jun 3.
10
Exercise training as therapy for heart failure: current status and future directions.运动训练作为心力衰竭的治疗方法:现状与未来方向。
Circ Heart Fail. 2015 Jan;8(1):209-20. doi: 10.1161/CIRCHEARTFAILURE.113.001420.